{"id":1065267,"date":"2012-06-04T22:10:41","date_gmt":"2012-06-04T22:10:41","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/viropharma-announces-initiation-of-clinical-studies-to-evaluate-maribavir-for-treatment-of-cytomegalovirus-cmv\/"},"modified":"2024-08-18T11:10:56","modified_gmt":"2024-08-18T15:10:56","slug":"viropharma-announces-initiation-of-clinical-studies-to-evaluate-maribavir-for-treatment-of-cytomegalovirus-cmv-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/ataxia\/viropharma-announces-initiation-of-clinical-studies-to-evaluate-maribavir-for-treatment-of-cytomegalovirus-cmv-2.php","title":{"rendered":"ViroPharma Announces Initiation of Clinical Studies to Evaluate Maribavir for Treatment of Cytomegalovirus (CMV &#8230;"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p> EXTON, Pa., June 4, 2012 \/PRNewswire\/ -- ViroPharma Incorporated (VPHM) today announced the initiation of a Phase 2 program to evaluate maribavir for the treatment of cytomegalovirus infections in transplant recipients. The planned program will consist of two independent Phase 2 clinical studies that will include subjects at different ends of the spectrum of CMV infection or disease, namely those who have asymptomatic CMV, and those who have failed therapy with other anti-CMV agents.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/ataxia\/viropharma-announces-initiation-of-clinical-studies-to-evaluate-maribavir-for-treatment-of-cytomegalovirus-cmv-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246881],"tags":[],"class_list":["post-1065267","post","type-post","status-publish","format-standard","hentry","category-ataxia"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1065267"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1065267"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1065267\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1065267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1065267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1065267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}